Celgene News - CELG

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
LEVEL 1 STARTER
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Celgene Corporation CELG NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.48 0.51% 95.22 95.50 94.72 94.76 94.74 19:59:48
more quote information »

Recent News

Date Time Source Heading
8/19/20198:02IHNWFeaturedInnerScope Hearing Technologies (OTCQB: INND) To Launch 100 Hearing Screening Kiosks to BENZER PHARMACY in 100 Locations
8/19/20199:12IHNWFeaturedGNBT Acquires Additional 38% of Subsidiary Olararegen Therapeutix with a Share Exchange of GNBT Stock at $2.50
8/16/201911:14DJNFDA Grants Approval to Celgene's Impact for Bone Marrow..
8/16/201910:30BWU.S. FDA Approves INREBIC® (Fedratinib) as First New..
8/05/201916:01EDGARStatement of Changes in Beneficial Ownership (4)
7/30/201916:12EDGARQuarterly Report (10-q)
7/30/201908:43DJNSecond-Quarter Revenue at Celgene Surpasses Wall Street..
7/30/201907:43EDGARCurrent Report Filing (8-k)
7/30/201907:30BWCelgene Reports Second Quarter 2019 Operating and Financial..
7/29/201910:10BWBristol-Myers Squibb Announces European Commission Approval..
7/26/201913:24GLOBEHach Rose Schirripa & Cheverie LLP Announces $55 Million..
7/25/201908:13DJNBristol-Myers Squibb Reports Higher Profit, Revises..
7/24/201907:30BWCelgene & the Multiple Sclerosis Association of America..
7/23/201916:00GLOBEJounce Therapeutics Announces Update on Strategic..
7/19/201914:47DJNCelgene Says FDA Approves Otezla for Oral Ulcers in Behcet's..
7/19/201913:59BWFDA Approves OTEZLA® (apremilast) for the Treatment of Oral..
7/16/201909:25DJNZymeworks Says Celgene Selects Lead Oncology Therapeutic..
6/26/201903:02DJNFacing Challenges, Firms Seek Deals -- WSJ
6/25/201903:02DJNCelgene Deal Faces Antitrust Delays -- WSJ
6/24/201915:30DJNBristol-Myers, Celgene Shares Both Lower as Merger Faces..
6/24/201914:36DJNAntitrust Concerns Delay Bristol-Myers' $74 Billion Merger..
6/24/201912:19DJNBristol-Myers' Celgene Deal Can Still Be a Winner -- Heard..
6/24/201909:37DJNStocks to Watch: Caesars, Bristol-Myers, Carnival, FedEx,..
6/24/201908:53DJNBristol-Myers to Shed Otezla, Carving Path for Celgene Deal
6/24/201906:59BWBristol-Myers Squibb Provides Update on Pending Merger with..
6/17/201916:01EDGARStatement of Changes in Beneficial Ownership (4)
6/17/201916:01EDGARStatement of Changes in Beneficial Ownership (4)
6/17/201916:01EDGARStatement of Changes in Beneficial Ownership (4)
6/17/201916:01EDGARStatement of Changes in Beneficial Ownership (4)
6/17/201908:13DJNBeiGene Says Agrees to End Collaboration With Celgene
6/14/201909:00PRNUSLeoplus USA Wins Lyfebulb-Celgene 2019 "Addressing Unmet..
6/13/201908:56DJNMereo BioPharma Says Celgene Won't License Etigilimab
6/06/201907:30BWUS FDA and EMA Accept Applications for Ozanimod for the..
6/06/201903:02DJNBristol to Shuffle R&D Executives -- WSJ
6/05/201916:07EDGARStatement of Changes in Beneficial Ownership (4)
6/05/201916:07EDGARStatement of Changes in Beneficial Ownership (4)
6/05/201916:07EDGARStatement of Changes in Beneficial Ownership (4)
6/05/201916:07EDGARStatement of Changes in Beneficial Ownership (4)
6/05/201916:07EDGARStatement of Changes in Beneficial Ownership (4)
6/05/201916:06EDGARStatement of Changes in Beneficial Ownership (4)
6/05/201916:06EDGARStatement of Changes in Beneficial Ownership (4)
6/05/201916:06EDGARStatement of Changes in Beneficial Ownership (4)
6/05/201907:28DJNBristol R&D Chief to Leave After Celgene Acquisition
6/05/201906:59BWBristol-Myers Squibb Announces Post-Closing Leadership Team
6/04/201911:00BWCelgene Announces Data from Ongoing Studies of Liso-Cel in..
6/04/201908:24DJNFDA Accepts Celgene, Acceleron BLA for Anemia Drug..
6/04/201907:30BWCelgene Corp. & Acceleron Pharma Announce U.S. FDA Accepts..
6/03/201909:00BWCelgene Updated Analysis of JAKARTA2 Fedratinib Study Shows..
6/02/201912:45BWCelgene Presents Data from a Phase 1/2 Clinical Study of..
5/28/201913:10DJNCelgene Says FDA Approves Revlimid in Combination with..
5/28/201912:30BWFDA Approves REVLIMID® (Lenalidomide) In Combination With..
5/28/201910:56BWCELGENE ERHÄLT ZULASSUNGEN DER EUROPÄISCHEN KOMMISSION FÜR..
See more news about this stock »


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.